Intangible Assets (Tables)

12 Months Ended

Sep. 30, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Intangible assets at September 30, 2013 and 2012 consist of the following:

	Useful	Gross		Accumulated
September 30, 2013	Life (years)	Amount		Amortization		Net
Acquired Customer Base	5 to 15	$	5,145,638	$	2,645,715	$	2,499,923
Know How	15	$	512,000	$	179,283		332,717
Trade Names	15 or Indefinite	$	547,802	$	75,856		471,946
Biomedical Technologies	5	$	300,000	$	120,003		179,997
		$	6,505,440	$	3,020,857	$	3,484,583

	Useful	Gross		Accumulated
September 30, 2012	Life (years)	Amount		Amortization		Net
Acquired Customer Base	5 to 15	$	7,858,775	$	2,257,533	$	5,601,242
Know How	15		512,000		145,147		366,853
Trade Names	15 or Indefinite		558,435		63,222		495,213
Biomedical Technologies	5		300,000		60,003		239,997
		$	9,229,210	$	2,525,905	$	6,703,305

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Amortization expense for the years ended September 30, 2013 and 2012 was $491,974 and $802,511 respectively. Estimated amortization expense for each of the next five fiscal years is as follows:

	2014		2015		2016		2017		2018		Thereafter		Total
Acquired Customer Base	$	233,079	$	233,079	$	233,079	$	233,079	$	233,079	$	1,334,528	$	2,499,923
Know How		34,214		34,214		34,214		34,214		34,214		161,647		332,717
Trade Names		14,600		14,600		14,600		14,600		14,600		61,161		134,161
Biomedical Technologies		60,000		60,000		59,997		-		-		-		179,997
	$	341,893	$	341,893	$	341,890	$	281,893	$	281,893	$	1,557,336	$	3,146,798